SARAH KEENE: Open Payments
NPI 1336697796 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,036 in 39 payments from 11 companies in 2025. Trend: 2023 $178 · 2024 $1,713 · 2025 $15,036
Speaker / faculty: $7,613Consulting: $3,500Travel & lodging: $2,693Food & beverage: $1,230
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 17 | $10,230 |
| Genentech USA, Inc. | 10 | $4,356 |
| Genentech, Inc. | 1 | $139 |
| ACADIA Pharmaceuticals Inc | 1 | $109 |
| ABBVIE INC. | 4 | $87 |
| Amgen Inc. | 1 | $23 |
| SOBI, INC | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Celgene Corporation | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $16 |
Products named: BRIUMVI, Ocrevus, NUPLAZID, RINVOQ, Ocrevus Zunovo, SKYRIZI, UPLIZNA, Gamifant.
Industry payments across KY — which companies pay providers there.
